APP education via training and professional development (APP and physician perceptions)
| Educational experience . | APPs . | Physicians∗ . |
|---|---|---|
| Specialty-specific education (select all that apply) | (n = 763) | |
| Onboarding or on-the-job training | 660 (86.5%) | |
| Independent study | 365 (47.8%) | |
| During NP or PA education | 321 (42.1%) | |
| Fellowship before starting job | 38 (5.0%) | |
| Fellowship as part of job | 20 (2.6%) | |
| Other | 72 (9.4%) | |
| Length of training needed | (n = 763) | |
| <6 mo | 586 (76.8%) | |
| 6-12 mo | 129 (16.9%) | |
| 13-24 mo | 24 (3.2%) | |
| >24 mo | 2 (0.3%) | |
| Not sure or still in training | 22 (2.9%) | |
| Professional development resources desired (current job) | ||
| Cytopenias | 77.5% (574/741) | |
| Thrombosis/hemostasis | 65.3% (482/738) | |
| Lymphoma | 65.0% (483/743) | |
| Myeloma and other plasma cell disorders | 62.5% (462/739) | |
| Leukemia | 62.1% (458/738) | |
| Hemoglobinopathies | 41.8% (314/751) | |
| Professional development resources desired (overall expertise) | ||
| Hemoglobinopathies | 51.4% (386/751) | |
| Stem cell/bone marrow transplantation & cellular therapies | 47.0% (347/738) | |
| Thrombosis/hemostasis | 41.3% (305/738) | |
| Lymphoma | 40.1% (298/743) | |
| Myeloma & other plasma cell disorders | 40.1% (296/739) | |
| Leukemia | 39.0% (288/738) | |
| Cytopenias | 36.7% (272/741) | |
| Training tools used by APPs | (n = 763) | (n = 1081) |
| Online resources designed for APPs | 661 (86.6%) | 535 (49.5%) |
| In-person teaching sessions designed for APPs | 583 (76.4%) | 546 (50.5%) |
| In-person or virtual professional meetings | 567 (74.3%) | 649 (60.0%) |
| Online resources designed for physicians | 442 (57.9%) | 364 (33.7%) |
| In-person teaching sessions designed for physicians | 425 (55.7%) | 561 (51.9%) |
| Other | 36 (4.7%) | 42 (3.9%) |
| Don’t know | - | 221 (20.4%) |
| Physician resources desired (% very helpful) | ||
| Working with APPs in outpatient care | 49.6% (521/1057) | |
| Working with APPs in inpatient care | 55.7% (589/1050) | |
| Working with APPs on research projects | 32.8% (343/1047) |
| Educational experience . | APPs . | Physicians∗ . |
|---|---|---|
| Specialty-specific education (select all that apply) | (n = 763) | |
| Onboarding or on-the-job training | 660 (86.5%) | |
| Independent study | 365 (47.8%) | |
| During NP or PA education | 321 (42.1%) | |
| Fellowship before starting job | 38 (5.0%) | |
| Fellowship as part of job | 20 (2.6%) | |
| Other | 72 (9.4%) | |
| Length of training needed | (n = 763) | |
| <6 mo | 586 (76.8%) | |
| 6-12 mo | 129 (16.9%) | |
| 13-24 mo | 24 (3.2%) | |
| >24 mo | 2 (0.3%) | |
| Not sure or still in training | 22 (2.9%) | |
| Professional development resources desired (current job) | ||
| Cytopenias | 77.5% (574/741) | |
| Thrombosis/hemostasis | 65.3% (482/738) | |
| Lymphoma | 65.0% (483/743) | |
| Myeloma and other plasma cell disorders | 62.5% (462/739) | |
| Leukemia | 62.1% (458/738) | |
| Hemoglobinopathies | 41.8% (314/751) | |
| Professional development resources desired (overall expertise) | ||
| Hemoglobinopathies | 51.4% (386/751) | |
| Stem cell/bone marrow transplantation & cellular therapies | 47.0% (347/738) | |
| Thrombosis/hemostasis | 41.3% (305/738) | |
| Lymphoma | 40.1% (298/743) | |
| Myeloma & other plasma cell disorders | 40.1% (296/739) | |
| Leukemia | 39.0% (288/738) | |
| Cytopenias | 36.7% (272/741) | |
| Training tools used by APPs | (n = 763) | (n = 1081) |
| Online resources designed for APPs | 661 (86.6%) | 535 (49.5%) |
| In-person teaching sessions designed for APPs | 583 (76.4%) | 546 (50.5%) |
| In-person or virtual professional meetings | 567 (74.3%) | 649 (60.0%) |
| Online resources designed for physicians | 442 (57.9%) | 364 (33.7%) |
| In-person teaching sessions designed for physicians | 425 (55.7%) | 561 (51.9%) |
| Other | 36 (4.7%) | 42 (3.9%) |
| Don’t know | - | 221 (20.4%) |
| Physician resources desired (% very helpful) | ||
| Working with APPs in outpatient care | 49.6% (521/1057) | |
| Working with APPs in inpatient care | 55.7% (589/1050) | |
| Working with APPs on research projects | 32.8% (343/1047) |
Reporting about APP colleagues.